Literature DB >> 11758293

A fallacy of the multiplicative QALY model for low-quality weights in students and patients judging hypothetical health states.

P F Stalmeier1, G B Chapman, A G de Boer, J J van Lanschot.   

Abstract

OBJECTIVES: In quality-adjusted life-years (QALY) models, it is customary to weigh life-years with quality of life via multiplication. As a consequence, for positive health states a longer duration has more QALYs than a shorter duration (i.e., longer is better). However, we have found that for poor health states, many prefer to live only a limited amount of time (i.e., longer is worse). Such preferences are said to be maximum endurable time (MET). In the present contribution, the following questions are asked: a) How low does the utility have to be in order for a MET to arise? and b) Do MET preferences occur when patients judge hypothetical health states? METHODS AND
RESULTS: We reanalyzed data from 176 students for the hypothetical health states of "living with migraines" and "living with metastasized cancer." For utilities smaller than 0.7 (ranging from 0 to 1), the MET preference rate was larger than 50%. High MET preference rates were also found in two new studies on migraine and esophageal cancer patients, who evaluated hypothetical health states related to their disease.
CONCLUSIONS: We discuss the interpretation of the MET preferences and the preference reversal phenomenon. Standard QALY models imply that longer is better. However, we find that more often, longer is worse for poorly evaluated health states. Consider the following question: are 3 years with a weight of 0.3 equally as valuable as 1 year with a weight of 0.9? Our results suggest that the 3-year period may be less valuable because for poor health, many will prefer a 1-year over a 3-year period.

Entities:  

Mesh:

Year:  2001        PMID: 11758293     DOI: 10.1017/s026646230110704x

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  13 in total

1.  Empirical validation of patient versus population preferences in calculating QALYs.

Authors:  Eva-Julia Weyler; Afschin Gandjour
Journal:  Health Serv Res       Date:  2011-04-21       Impact factor: 3.402

Review 2.  Using QALYs in cancer: a review of the methodological limitations.

Authors:  Martina Garau; Koonal K Shah; Anne R Mason; Qing Wang; Adrian Towse; Michael F Drummond
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

3.  Maximal endurable time states and the standard gamble: more preference reversals.

Authors:  P F M Stalmeier; A L Verheijen
Journal:  Eur J Health Econ       Date:  2012-12-09

4.  Values for health states with different life durations.

Authors:  Luciana Scalone; Peep F M Stalmeier; Silvano Milani; Paul F M Krabbe
Journal:  Eur J Health Econ       Date:  2014-09-30

5.  The way that you do it? An elaborate test of procedural invariance of TTO, using a choice-based design.

Authors:  Arthur E Attema; Werner B F Brouwer
Journal:  Eur J Health Econ       Date:  2011-05-15

6.  On the (not so) constant proportional trade-off in TTO.

Authors:  Arthur E Attema; Werner B F Brouwer
Journal:  Qual Life Res       Date:  2010-02-12       Impact factor: 4.147

7.  Constantly proving the opposite? A test of CPTO using a broad time horizon and correcting for discounting.

Authors:  Arthur E Attema; Werner B F Brouwer
Journal:  Qual Life Res       Date:  2011-04-21       Impact factor: 4.147

8.  Health state utilities for migraine based on attack frequency: a time trade-off study.

Authors:  Fanni Rencz; Valentin Brodszky; Márta Péntek; Dániel Bereczki; László Gulácsi
Journal:  Neurol Sci       Date:  2014-08-10       Impact factor: 3.307

9.  Long-Term Cost Effectiveness of Interferon-beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis : An Econometric Model.

Authors:  Claude Lepen; Patricia Coyle; Timothy Vollmer; Lance Blumhardt; Hervé Lilliu; Ariel Beresniak
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

10.  Time trade-off: one methodology, different methods.

Authors:  Arthur E Attema; Yvette Edelaar-Peeters; Matthijs M Versteegh; Elly A Stolk
Journal:  Eur J Health Econ       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.